Capitalizing Disease: Biopolitics of Drug Trials in India

Theory, Culture & Society

Volumn 26, Issue 5, 2009, Pages 1-29

  Prasad, Amit ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

biopolitics; drug trials; governmentality; human capital; India; neoliberalism

Indexed keywords

EID: 70349220983     PISSN: 02632764     EISSN: None     Source Type: Journal    
DOI: 10.1177/0263276409106347     Document Type: Article

References (99)

1. Adkins, L. (2001) ‘Risk Culture, Self-reflexivity and the Making of Sexual Hierarchies’, Body & Society, 7(1): 35-55.
2. Agamben, G. (1998) Homo Sacer: Sovereign Power and Bare Life. Stanford, CA: Stanford University Press.
3. Azoulay, P. (2003) ‘Agents of Embeddedness’, National Bureau of Economic Research, Working Paper 10142, URL (consulted May 2009): www.nber.org/ papers/w10142
4. Balakrishnan, P. and A. Sharma (2004) ‘A New Healing Touch’, rediff.com 26 June, URL (consulted May 2009): http://inhome.rediff.com/money/2004/jun/26spec.htm
5. Barnes, K. (2007) ‘Clinical Trials in India Just Got Cheaper’, 28 February, URL (consulted February 2008): http://www.drugresearcher.com/news/ng.asp?id=74588
6. Barry, A., T. Osborne and N. Rose (1996) Foucault and Political Reason: Liberalism, Neo-liberalism and Rationalities of Government. Chicago: University of Chicago Press.
7. Becker, G. (1962) ‘Investment in Human Capital: A Theoretical Analysis’, Journal of Political Economy, 70(5): 9-49.
8. Becker, G. (1964) Human Capital. New York: Columbia University Press.
9. Becker, G. (1993) ‘Nobel Lecture: The Economic Way of Looking at Behavior’, Journal of Political Economy, 101(3): 385-409.
10. Best, J. (2007) ‘Why the Economy is Often the Exception to Politics as Usual’, Theory, Culture & Society, 24(4): 87-109.
11. ‘Biocon Buys 70% Stake in German Pharma Co for Euro 30m’, BusinessLine 12 February, URL (consulted May 2009): http://www.thehindubusinessline.com/2008/02/12/stories/2008021250980300.htm
12. Borfitz, D. (2008) ‘India Becoming Favored Destin ation for Clinical Trials’, 22 January, URL (consulted February 2008): www.bio-itworld.com/newsitems/2008/jan/22-clinical-trials-india
13. Braun, B. (2007) ‘Biopolitics and the Molecularization of Life’, Cultural Geographies, 14(6): 6-28.
14. Burchell, G., C. Gordon and P. Miller (1991) The Foucault Effect: Studies in Governmentality. Chicago: University of Chicago Press.
15. Callewaert, S. (2006) ‘Bourdieu, Critic of Foucault: The Case of Empirical Social Science against Double-Game-Philosophy’, Theory, Culture & Society, 23(6): 73-98.
16. Carney, S. (2005) ‘Testing Drugs on India's Poor’, Wired 19 December, URL (consulted May 2009): www.wired.com/medtech/drugs/news/2005/12/69595?currentPage=2
17. Chidambaram, P. (2007) ‘Budget 2007-08’, speech of Minister of Finance, 28 February, URL (consulted February 2008): http://indiabudget.nic.in/ub2007-08/bs/speecha.htm
18. Chopra, A. (2008) ‘Organ-transplant Black Market Thrives in India’, San Francisco Chronicle 9 February, URL (consulted February 2008): www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/02/09/MN23UPQ0K.DTL
19. Cohen, L. (2005) ‘Operability, Bioavailability, and Exception’, pp. 79-90 in A. Ong and S. Collier (eds) Global Assemblages: Technology, Politics, and Ethics as Anthropological Problems. Malden, MA: Blackwell.
20. Cooper, M. (2006) ‘Pre-empting Emergence: The Biological Turn in the War on Terror’, Theory, Culture & Society, 23(4): 113-35.
21. Cooper, M. (2008) Life as Surplus: Biotechnology and Capitalism in the Neoliberal Era. Seattle: University of Washington Press.
22. Coronil, F. (2001) ‘Toward a Critique of Globalcentrism: Speculations on Capitalism's Nature’, pp. 63-87 in J. Comaroff and J. Comaroff (eds) Millennial Capitalism and the Culture of Neoliberalism. Durham, NC: Duke University Press.
23. Das, V. (1999) ‘Public Good, Ethics, and Everyday Life: Beyond the Boundaries of Bioethics’, Daedulus, 128(4): 99-133.
24. Dean, M. (1999) Governmentality: Power and Rule in Modern Society. Thousand Oaks, CA: SAGE.
25. Deutsche Bank Research (2005) Outsourcing to India: Crouching Tiger Set to Pounce, report, 25 October, URL (consulted May 2009): http://www.dbresearch.com/PROD/DBR_INTERNET_EN-PROD/PROD0000000000192125.PDF
26. Dey, B. and P. Dey (2005) ‘Clinical Trials - Commerce versus Ethics’, Pharmabiz.com 4 May, URL (consulted February 2008): www.pharmabiz.com/article/detnews.asp?articleid=27444§ionid=46
27. Ecks, S. (2006) ‘How Global Corporate Citizenship is Translated to Doctors in India’, paper presented at annual conference of European Association of Social Anthropologists, Bristol, UK, 18-21 September.
28. Foucault, M. (1988) ‘Technologies of the Self’, pp. 16-49 in L. Martin, H. Gutman and P. Hutton (eds) Technologies of the Self: A Seminar with Michel Foucault. Amherst: University of Massachusetts Press.
29. Foucault, M. (1990) The History of Sexuality: An Introduction, vol. 1. New York: Vintage Books.
30. Foucault, M. (1991) ‘Governmentality’, pp. 87-104 in G. Burchell, C. Gordon and P. Miller (eds) The Foucault Effect: Studies in Governmentality. Chicago: University of Chicago Press.
31. Foucault, M. (2008) The Birth of Biopolitics: Lectures at the Collège de France, edited by M. Senellart. New York: Palgrave Macmillan.
32. Gentleman, A. (2007) ‘Setback for Novartis in India over Drug Patent’, New York Times 7 August, URL (consulted February 2008): www.nytimes.com/2007/08/07/business/worldbusiness/07drug.html?ref=health
33. Gordon, C. (1991) ‘Governmental Rationality: An Introduction’, pp. 1-51 in G. Burchell, C. Gordon and P. Miller (eds) The Foucault Effect: Studies in Governmentality. Chicago: University of Chicago Press.
34. Haraway, D. (1991) Simians, Cyborgs, and Women: The Reinvention of Nature. New York: Routledge.
35. Hardt, M. and A. Negri (2001) Empire. Cambridge, MA: Harvard University Press.
36. Hart, O. and J. Moore (2008) ‘Contracts as Reference Points’, Quarterly Journal of Economics, 123(1): 1-32.
37. Harvey, D. (2005) A Brief History of Neoliberalism. New York: Oxford University Press.
38. ICMR (Indian Council of Medical Research) (2006) Ethical Guidelines for Biomedical Research on Human Participants. New Delhi: Indian Council of Medical Research.
39. ‘India's Choice’ (2005) Editorial, New York Times 18 January.
40. Iype, G. (2004) ‘Clinical Trials: Why India Is Irresistible’, rediff.com 22 December, URL (consulted May 2009): http://www.rediff.com/money/2004/dec/22spec.htm
41. Joseph, J. (2008) ‘Entering the Contract Research Industry in India’, Contemporary Clinical Trials, 29(3): 311-13.
42. Kahn, J. (2006) ‘A Nation of Guinea Pigs’, Wired, 14(3), URL (consulted May 2009): http://www.wired.com/wired/archive/14.03/indiadrug.html
43. Krishnakumar, R. (2001) ‘Drug Trials and Ethics’, Frontline, 18(17).
44. Krishnakumar, R. (2005) ‘Erimos Has Broadened the Research: Interview with Ru Chih C. Huang, Biology Professor of Johns Hopkins University’, Frontline, 22(25).
45. Kumar, K. (forthcoming) ‘Empires and Nations: Convergence or Divergence’, in G. Steinmetz (ed.) Sociology and Empire. Durham, NC: Duke University Press.
46. Lash, S. (2006) ‘Life (Vitalism)’, Theory, Culture & Society, 22(2-3): 323-9.
47. Latour, B. (1993) We Have Never Been Modern. Cambridge : Cambridge University Press.
48. Lemke, T. (2001) ‘“The Birth of Bio-politics”: Michel Foucault's Lecture at the Collège de France on Neo-liberal Governmentality’, Economy and Society, 30(2): 190-207.
49. ‘Lobby Behind Every Exemption, Admits FM [Finance Ministry]’ (2008) Times of India 2 March 2008, URL (consulted March 2008): http://timesofindia.indiatimes.com/Lobby_behind_every_exemption_admits_FM/articleshow/msid-2830408,curpg-1.cms
50. Marx, K. (1977) Capital, vol. 1. New York: Vintage Books.
51. Mbembe, A. (2003) ‘Necropolitics’ (trans. Libby Meintjes), Public Culture, 15(1): 11-40.
52. Mica, D. (1995) Speech the debate on the Personal Responsibility Act of 1995, House of Representatives, United States, 24 March.
53. Mincer, J. (1958) ‘Investment in Human Capital and Personal Income Distribution’, Journal of Political Economy, 66(4): 281-302.
54. Mincer, J. (1974) Schooling, Experience, and Earnings. New York: Columbia University Press.
55. Ministry of Finance (2007) Economic Survey of India, Government of India, URL (consulted February 2008): http://indiabudget.nic.in/es2006-07/chapt2007/chap15.htm
56. Mirowski, P. and R. Van Horn (2005) ‘The Contract Research Organization and the Commercialization of Scientific Research’, Social Studies of Science, 35(4): 503-48.
57. ‘Monitor Clinical Trials’ (2007) Deccan Herald 7 December, URL (consulted February 2008): http://www.deccanherald.com/Content/Dec72007/national2007120739934.asp
58. Mudur, G.S. (2005) ‘Patients Turn Guinea Pigs Minus Cover’, The Telegraph (Calcutta) 24 October.
59. ‘National Briefing, Science and Health: University Sanctions Researcher’, (2001) New York Times 13 November: A 14, URL (consulted May 2009): http://www.nytimes.com/2001/11/13/us/national-briefing-science-and-health-university-sanctions-researcher.html
60. Nundy, S. and C.M. Gulhati (2005) ‘A New Colonialism? Conducting Clinical Trials in India’, New England Journal of Medicine, 352(16): 1633-6.
61. O'Connor, A. (2006) ‘India's New Outsourcing Remedy’, The Times 9 October.
62. O'Malley, P. (1996) ‘Risk and Responsibility’, pp. 189-207 in A. Barry, T. Osborne and N. Rose (eds) Foucault and Political Reason: Liberalism, Neo-liberalism and Rationalities of Government. Chicago: University of Chicago Press.
63. Ong, A. (1999) Flexible Citizenship: The Cultural Logics of Transnationality. Durham, NC: Duke University Press.
64. Ong, A. (2006) Neoliberalism as Exception: Mutations in Citizenship and Sovereignty. Durham, NC: Duke University Press.
65. Palladino, P. (2003) ‘The Politics of Death: On Life after “The End of History”’, Journal for Cultural Research, 7(3): 321-35.
66. Pasquino, P. (1991) ‘Theatrum Politicum: The Genealogy of Capital - Police and the State of Prosperity’, pp. 105-18 in G. Burchell, C. Gordon and P. Miller (eds) The Foucault Effect: Studies in Governmentality. Chicago: University of Chicago Press.
67. Petryna, A. (2007a) ‘Experimentality: On the Global Mobility and Regulation of Human Subjects Research’, PoLAR: Political and Legal Anthropology Review, 30(2): 288-304.
68. Petryna, A. (2007b) ‘Clinical Trials Offshored: On Private Sector Science and Public Health’, BioSocieties, 2: 21-40.
69. Petryna, A. and A. Kleinman (2006) ‘The Pharmaceutical Nexus’, pp. 1-32 in A. Petryna, A. Lakoff and A. Kleinman (eds) Global Pharmaceuticals: Ethics, Markets, Practices. Durham, NC: Duke University Press.
70. Piachaud, B.S. (2002) ‘Outsourcing in the Pharmaceutical Manufacturing Process: An Examination of the CRO Experience’, Technovation, 22: 81-90.
71. Pieterse, J.N. (2004) ‘Neoliberal Empire’, Theory, Culture & Society, 21(3): 119-40.
72. Planning Commission (2001) India as a Knowledge Superpower: Strategy for Transformation, Task Force Report. New Delhi: Government of India.
73. ‘Poetic Interlude’ (2008) Journal of Clinical Best Practices, 4(12).
74. Portes, A. (1997) ‘Neoliberalism and the Sociology of Development: Emerging Trends and Unanticipated Facts’, Population and Development Review, 23(2): 229-59.
75. Rabinow, P. (1996) Essays in the Anthropology of Reason. Princeton, NJ: Princeton University Press.
76. Rai, S. (2005) ‘Testing Gives India a Shot in the Arm’, International Herald Tribune 15 January.
77. Randeria, S. (2007) ‘The State of Globalization: Legal Plurality, Overlapping Sovereignties and Ambiguous Alliances between Civil Society and the Cunning State in India’, Theory, Culture & Society, 24(1): 1-33.
78. Rettig, R.A. (2000) ‘The Industrialization of Clinical Research’, Health Affairs, 19(2): 129-46.
79. Rncos (2007) Booming Clinical Trials Market in India, November, URL (consulted May 2009): http://www.canbiotech.com/CommonData/NewsFiles/Booming%20Clinical%20Trials%20Market%20in%20India.pdf
80. Rose, N. (1999) Powers of Freedom: Reframing Political Thought. Cambridge: Cambridge University Press.
81. Rose, N. (2007) The Politics of Life Itself: Biomedicine, Power, and Subjectivity in the Twenty-first Century. Princeton, NJ: Princeton University Press.
82. Shah, S. (2003) ‘Globalization of Clinical Research by the Pharmaceutical Industry’, International Journal of Health Services, 33(1): 29-36.
83. Shah, S. (2006) The Body Hunters: Testing New Drugs on the World's Poorest Patients. New York: The New Press.
84. Shuchman, M. (2007) ‘Commercializing Clinical Trials: Risks and Benefits of the CRO Boom’, New England Journal of Medicine, 357(14): 1365-8.
85. Shultz, T. (1961) ‘Investment in Human Capital’, American Economic Review, 51(1): 1-17.
86. Smith, A. (2007) ‘India's Elephant in the Room: Weak Patent Laws’, CNNMoney.com 4 May, URL (consulted May 2009): http://money.cnn.com/2007/05/04/news/companies/india_biotech/index.htm
87. Special Correspondent (2005a) ‘Dr Reddy's Starts Trials for New Drug’, The Telegraph (Calcutta, India) 8 February.
88. Special Correspondent (2005b) ‘Human Guinea Pigs Queue for Cash as Drug Firms Rush to India’, Agence France Press, 29 September.
89. Srinivasan, S. (2005) ‘Clinical Trials - Part III: India Is Being Projected as a Global Hub of Clinical Trials’, URL (consulted February 2008): http://www.infochangeindia.org/features308.jsp
90. Sunder Rajan, K. (2005) ‘Subjects of Speculation: Emergent Life Sciences and Market Logics in the United States and India’, American Anthropologist, 107(1): 19-30.
91. Sunder Rajan, K. (2006) Biocapital: The Constitution of Postgenomic Life. Durham, NC: Duke University Press.
92. Thrift, N. (2006) ‘Re-inventing Invention: New Tendencies in Capitalist Commodification’, Economy and Society, 35(2): 279-306.
93. Tobias, S. (2005) ‘Foucault on Freedom and Capabilities’, Theory, Culture & Society, 22(4): 65-85.
94. Venn, C. (2000) Occidentalism: Modernity and Subjectivity. Thousand Oaks, CA: SAGE.
95. Venn, C. (2007) ‘Cultural Theory, Biopolitics, and the Question of Power’, Theory, Culture & Society, 24(3): 111-24.
96. Wacquant, L. (2001) ‘Whores, Slaves and Stallions: Languages of Exploitation and Accommodation among Boxers’, Body & Society, 7(2-3): 181-94.
97. Weber, E. (1976) Peasants into Frenchmen: The Modernization of Rural France, 1870-1914. Stanford, CA: Stanford University Press.
98. World Bank (1997) Expanding the Measure of Wealth: Indicators of Environmentally Sustainable Development. Washington, DC: World Bank.
99. World Health Organization (2005) ‘Access to Medicines - Intellectual Property Protection: Impact on Public Health’, WHO Drug Information, 19(3): 236-41.